First-line Canakinumab Without Steroids Shows Effectiveness for Systemic Juvenile Idiopathic ArthritisJune 26, 2024Rare DiseasesMusculoskeletal Disorders
Oncology Mergers Are on the Rise. How Can Independent Practices Survive?June 25, 2024Mixed TopicsOncologyBusiness of Medicine
Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related ArthritisJune 24, 2024Mixed Topics
See the Medical World Through Neurodivergent Doctors’ EyesJune 24, 2024Diversity in MedicineBusiness of Medicine
Atopic Dermatitis: Study Compares Prevalence by Gender, Age, and Ethnic BackgroundJune 24, 2024DermatologyMixed TopicsAdolescent Medicine
Pediatric Atopic Dermatitis: Study Suggests Treatment May Impact Atopic MarchJune 21, 2024DermatologyAsthma
US Hospitals Prone to Cyberattacks Like One That Impacted Patient Care at Ascension, Experts SayJune 21, 2024Business of Medicine
